Radiation Oncology, Department ofFeed

People

  1. Mueller
    Mueller
  2. Barker
    Barker
  3. Tsai
    Tsai
  4. Cuaron
    Cuaron
  5. Crane
    Crane
  6. Beal
    Beal
  7. LaPlant
    LaPlant
  8. Bakhoum
    Bakhoum
  9. Wu
    Wu
  10. Gelblum
    Gelblum
  11. Shasha
    Shasha
  12. Mychalczak
    Mychalczak
  13. Zinovoy
    Zinovoy
  14. Shepherd
    Shepherd
  15. Schmitt
    Schmitt

Description

Publications

  1. International Journal of Radiation Oncology, Biology, Physics (1441)
  2. Journal of Clinical Oncology (357)
  3. Medical Physics (176)
  4. Radiotherapy and Oncology (98)
  5. Gynecologic Oncology (96)
  6. Cancer (91)
  7. Pediatric Blood and Cancer (86)
  8. Brachytherapy (78)
  9. Blood (74)
  10. Cancer Research (73)

Publishers

  1. Elsevier Inc. (2024)
  2. American Society of Clinical Oncology (364)
  3. Elsevier Science, Inc. (217)
  4. Springer (192)
  5. Lippincott Williams & Wilkins (185)
  6. American Association of Physicists in Medicine (176)
  7. Wiley Blackwell (176)
  8. Oxford University Press (141)
  9. Nature Publishing Group (105)
  10. Wiley Periodicals, Inc (87)

Types of Work

Ajax loader

Recent Works

  1. Discordance of patient- and physician-reported toxicities in two prospective trials of stereotactic body radiotherapy (SBRT) for localized prostate cancer
    Meeting Abstract

    Patel, A.; Badia, R. R.; Amini, A.; Kung, C.; Kusin, S. B.; Neufeld, S.; Mannala, S.; Garant, A.; Hannan, R.; Timmerman, R. D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  2. Favorable toxicity of chemoradiation for muscle-invasive bladder cancer in elderly, frail patients
    Meeting Abstract

    Moore, A.; Zhang, Z.; Bochner, B. H.; Donahue, T. F.; Rosenberg, J. E.; Iyer, G.; Funt, S. A.; Bajorin, D. F.; Teo, M. Y.; Aggen, D. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  3. DASL-HiCaP: Darolutamide augments standard therapy for localized very high-risk cancer of the prostate (ANZUP1801). A randomized phase 3 double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation
    Meeting Abstract

    McBride, S. M.; Niazi, T.; Williams, S.; Davis, I. D.; Stockler, M. R.; Martin, A. J.; Bracken, K.; Roncolato, F. T.; Horvath, L.; Sengupta, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save